 | FY2018 Earnings Estimate for Amgen, Inc. Issued By Leerink Swann (AMGN)
www.americanbankingnews.com - September 18 at 7:34 AM |
 | World's Largest Alzheimer's Survey Reveals Most Adults Believe a Cure Will be Developed in Their Lifetime
finance.yahoo.com - September 17 at 5:28 PM |
| Amgen (AMGN) Given a $209.00 Price Target at Leerink Swann
www.americanbankingnews.com - September 17 at 12:03 PM |
 | Is Now a Good Time to Buy Amgen?
www.fool.com - September 15 at 9:11 AM |
 | Is Amgen (AMGN) a Great Stock for Value Investors?
www.msn.com - September 14 at 5:12 PM |
 | Amgen's (AMGN) Management on BofAML Global Health Conference 2018 - Transcript
seekingalpha.com - September 14 at 5:12 PM |
| Why Amgen Will Likely Be a Boring Dividend Stock Over the Next Few Years
finance.yahoo.com - September 13 at 8:05 AM |
| $5.76 Billion in Sales Expected for Amgen, Inc. (AMGN) This Quarter
www.americanbankingnews.com - September 13 at 3:58 AM |
| Amgen's (AMGN) CEO Bob Bradway on Morgan Stanley Healthcare Conference - Transcript
seekingalpha.com - September 12 at 5:01 PM |
| Amgen (AMGN) Given a $220.00 Price Target at Jefferies Financial Group
www.americanbankingnews.com - September 12 at 10:42 AM |
| Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
finance.yahoo.com - September 11 at 5:04 PM |
| Amgen, Inc. (AMGN) Expected to Post Earnings of $3.38 Per Share
www.americanbankingnews.com - September 11 at 10:52 AM |
| Amgen Looks To Enter Multiple Myeloma Space: Can It Compete?
seekingalpha.com - September 11 at 8:02 AM |
| Amgen's Aimovig Launch Looks Strong; Monitor Biosimilar Developments
seekingalpha.com - September 11 at 8:02 AM |
 | Recent AMGN News
www.bloomberg.com - September 10 at 5:07 PM |
| Amgen (AMGN) Given a $193.00 Price Target by Royal Bank of Canada Analysts
www.americanbankingnews.com - September 10 at 12:08 PM |
| Amgen (AMGN) Given a $224.00 Price Target at Oppenheimer
www.americanbankingnews.com - September 10 at 10:44 AM |
| Amgen To Present At The Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 7 at 5:17 PM |
 | AstraZeneca, Amgen Announce Breakthrough Therapy Designation For Tezepelumab
www.nasdaq.com - September 7 at 8:03 AM |
| AstraZeneca gets FDA breakthrough therapy label for asthma treatment
finance.yahoo.com - September 7 at 8:03 AM |
| Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype
finance.yahoo.com - September 7 at 8:03 AM |
 | Hospital groups launch own company to make generic drugs
marketbeat.com - September 6 at 12:18 AM |
| [$$] Biotech Veterans Raise $320 Million for New Life Sciences Venture Fund
finance.yahoo.com - September 5 at 5:19 PM |
| Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.
finance.yahoo.com - September 2 at 8:01 AM |
| Amgen's Leukemia Drug Blincyto Gets EU Nod for Pediatric Use
finance.yahoo.com - August 30 at 5:37 PM |
| Expanded use of Amgen's Blincyto OK'd in Europe
seekingalpha.com - August 29 at 5:11 PM |
 | Amgen (AMGN) Says EC Approves BLINCYTO For Use In Pediatric Patients With Philadelphia Chromosome-Negative R/R B-Cell Precursor ALL
www.streetinsider.com - August 29 at 5:11 PM |
| Amgen (AMGN) PT Set at $197.00 by Wells Fargo & Co
www.americanbankingnews.com - August 29 at 10:46 AM |
| Amgen Seeks US Approval for Its KYPROLIS in a Combo for Multiple Myeloma
finance.yahoo.com - August 28 at 5:08 PM |
| Oppenheimer Reiterates $224.00 Price Target for Amgen (AMGN)
www.americanbankingnews.com - August 28 at 11:27 AM |
| Amgen files U.S. marketing application for weekly regimen of Kyprolis
seekingalpha.com - August 27 at 5:23 PM |
 | Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone
www.bizjournals.com - August 27 at 5:23 PM |
| Amgen Submits SNDA For KYPROLIS - Quick Facts
www.nasdaq.com - August 27 at 5:23 PM |
| Why Is Amgen (AMGN) Up 1.3% Since Last Earnings Report?
finance.yahoo.com - August 27 at 9:13 AM |
| Amgen, Inc. (AMGN) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 26 at 2:38 AM |
| Your Cancer Research Highlight: Bristol-Myers Looks For An In To Earlier Multiple Myeloma
seekingalpha.com - August 24 at 5:20 PM |
| 3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?
finance.yahoo.com - August 24 at 5:20 PM |
| Amgen (AMGN) PT Set at $220.00 by Jefferies Financial Group
www.americanbankingnews.com - August 24 at 1:44 PM |
| Own A Bond Instead Of Ford - Cramer's Lightning Round (8/22/18)
seekingalpha.com - August 23 at 8:04 AM |
| Cramer's lightning round: Pick this stock for a biotech p...
finance.yahoo.com - August 23 at 8:04 AM |
 | Trade of the Day: Amgen Is a Strong Stock in a Giddy Industry
investorplace.com - August 23 at 7:42 AM |
| Is Amgen Inc. a Buy?
www.fool.com - August 22 at 6:54 AM |
| Brokers Offer Predictions for Amgen, Inc.'s Q3 2018 Earnings (AMGN)
www.americanbankingnews.com - August 22 at 5:49 AM |
| Amgen To Present Robust Data Exploring The Impact Of Treatment With Repatha® (evolocumab) Across Patient Subgroups And High-Risk Populations At ESC Congress 2018
finance.yahoo.com - August 21 at 8:03 AM |
| Recent Developments for Amgen since Q2 2018
finance.yahoo.com - August 21 at 8:03 AM |
| Amgen’s Product Performance in Q2 2018
finance.yahoo.com - August 21 at 8:03 AM |
| FY2019 EPS Estimates for Amgen, Inc. (AMGN) Lifted by Analyst
www.americanbankingnews.com - August 21 at 7:23 AM |
 | Amgen Stock Up This Year So Far: Will the Rally Continue?
www.zacks.com - August 20 at 9:15 AM |
| [$$] Gormley's Take: Cancer-Killing Viruses Catch On With VCs
finance.yahoo.com - August 17 at 8:10 AM |
| Amgen: Cramer Discusses the AAP Portfolio's New Edition
finance.yahoo.com - August 15 at 5:37 PM |
